知镜 Cognispect · 医学文献与研究工作台

Extracellular Vesicles in Acute Myeloid Leukemia: Opportunities and Obstacles for Therapeutic Advancement.

Hu R, Ataullev Z, Lou L.
Journal of biochemical and molecular toxicology · 2026-08-01 · PMID 42478125

文献摘要

Acute myeloid leukemia (AML) is a disease characterized by uncontrolled proliferation and blocked maturation of hematopoietic stem and progenitor cells. Despite progress in its clinical management, many patients continue to relapse or show limited response to standard therapies, emphasizing the need for novel, safe, and more effective targeted treatment approaches. In recent years, research has increasingly focused on uncovering the mechanisms responsible for treatment failure to optimize therapeutic strategies. Particular attention has been directed toward the role of extracellular vesicles (EVs) released by AML cells and the ways in which the tumor microenvironment (TME) adapts to promote leukemia progression and survival. Concurrently, advances in biotechnology have led to growing interest in using EVs as therapeutic tools in hematologic malignancies. EVs can function as carriers that induce apoptosis in cancer cells or suppress oncogene expression through their RNA cargo. Therefore, this review aims to synthesize and discuss recent discoveries on the roles and therapeutic potential of EVs in AML.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。